Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 10, 2023 09:00 ET | Source: InSilico Medicine

Insilico Medicine announces positive topline results of the New Zealand Phase 1 trial of INS018_055, an AI-designed drug for an AI-discovered target

New York, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Insilico Medicine (“Insilico”), a clinical stage artificial intelligence (AI)-driven drug R&D company, today announces positive topline results of...
January 04, 2023 06:48 ET | Source: Research and Markets

Opportunities in the Artificial Intelligence in Drug Discovery Market Investor Report: Savings of $8.57 Billion Enabled by AI

Dublin, Jan. 04, 2023 (GLOBE NEWSWIRE) -- The "Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market" report has been added to ResearchAndMarkets.com's offering. ...
November 07, 2022 08:38 ET | Source: Research and Markets

Computer-Aided Drug Discovery Global Market Report 2022: Demand for Novel Drugs to Treat CVD Conditions Fuels Growth

Dublin, Nov. 07, 2022 (GLOBE NEWSWIRE) -- The "Computer-Aided Drug Discovery Market By Type, By Therapeutic Area, By End User: Global Opportunity Analysis and Industry Forecast, 2021-2030" report...
July 07, 2022 09:00 ET | Source: InSilico Medicine

Insilico Medicine identified multiple new targets for amyotrophic lateral sclerosis (ALS) using its AI-driven target discovery engine

New York, July 07, 2022 (GLOBE NEWSWIRE) -- Insilico Medicine, a clinical-stage end-to-end artificial intelligence (AI)-driven drug discovery company, announced today that the company has identified...
February 17, 2022 05:58 ET | Source: Research and Markets

Global In-Silico Drug Discovery Market to 2031 - Focus on Product, Workflow, Technology and End-user

Dublin, Feb. 17, 2022 (GLOBE NEWSWIRE) -- The "In-Silico Drug Discovery Market: Focus on Product, Workflow, Technology, and End User - Analysis and Forecast, 2021-2031" report has been added to...
September 29, 2021 05:53 ET | Source: Research and Markets

Global Drug Discovery Informatics Market Report 2021: Discovery Workflow Segment Accounted for the Largest Share of 59.19% in 2020 - Forecast to 2028

Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "Global Drug Discovery Informatics Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global drug discovery informatics...
May 05, 2021 04:18 ET | Source: Research and Markets

Global $1.88 Billion Quantitative Structure-Activity Relationship Market to 2027: Increasing Adoption of Modeling Tools in Drug Discovery & Economic Burden of Drug Discovery

Dublin, May 05, 2021 (GLOBE NEWSWIRE) -- The "Quantitative Structure-Activity Relationship Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Application; Industry, and Geography"...
March 03, 2021 16:01 ET | Source: BlossomHill Therapeutics, Inc.

BlossomHill Therapeutics Closes $71M Series A Financing

SAN DIEGO, March 03, 2021 (GLOBE NEWSWIRE) -- BlossomHill Therapeutics, Inc., a biopharmaceutical company focusing on oncology and autoimmune disorders, announced today that the company raised $71...
February 18, 2021 04:33 ET | Source: Research and Markets

Global AI-based Drug Discovery Markets 2020-2030: Focus on Deep Learning and Machine Learning

Dublin, Feb. 18, 2021 (GLOBE NEWSWIRE) -- The "AI-based Drug Discovery Market: Focus on Deep Learning and Machine Learning, 2020-2030" report has been added to ResearchAndMarkets.com's offering. ...
May 15, 2019 11:54 ET | Source: Reports And Data

In Vitro Diagnostics (IVD) Market To Reach USD 99.46 Billion By 2026 | Reports And Data

Growth in the geriatric population and the widespread prevalence of chronic and infectious disease is fueling the market demand. Market Size – USD 69.43 Billion in 2018, Market Growth - CAGR of...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right